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Abstract
Background: Image guided radiotherapy (IGRT) is an essential pre-requisite for delivering high precision
radiotherapy. We compared daily variation detected by two non-ionizing imaging modalities (surface imaging and
trans-abdominal ultrasound, US) to verify prostate patient setup and internal organ variations.
Methods: Forty patients with organ confined prostate cancer and candidates to curative radiotherapy were
enrolled in this prospective study. At each treatment session, after laser alignment, all patients received imaging by
a 3D-surface and a 3D-US system. The shifts along the three directions (anterior-posterior AP, cranial-caudal CC, and
later-lateral LL) were measured in terms of systematic and random errors. Then, we performed statistical analysis on
the differences and the possible correlations between the two modalities.
Results: For both IGRT modalities, surface imaging and US, 1318 acquisitions were collected. According with Shapiro
Wilk test, the positioning error distributions were not Gaussian for both modalities.
The differences between the systematic errors detected by the two modalities were statistically significant only in LL
direction (p < 0.05), while the differences between the random errors were not statistically significant in any directions.
The 95% confidence interval of the residual errors obtained by subtracting the random errors detected with surface
images to those detected with US was included in the range from −7 mm to 7 mm corresponding to the minimum
PTV margin adopted in AP direction in our clinical routine.
Conclusions: From our data, it emerges that setup misalignments measured by surface imaging can be predictive of
US displacements after the adjustment for systematic errors. Moreover, surface imaging can detect setup errors
predictive of registration errors measured by US. This data suggest that the two IGRT modalities could be considered
as complementary to each other and could represent a daily “low-cost” and non-invasive IGRT modality in prostate
cancer patients.
Keywords: Prostate cancer, Image-guided radiotherapy, 3D-surface imaging, 3D-ultrasound
Background
Accurate and reproducible patient setup is a pre-
requisite to correctly deliver fractionated radiother-
apy for prostate cancer. To correct for daily setup
errors and inter-fraction organ motion, image guided
radiation therapy (IGRT) is used, allowing for
decreased safety margins and reduced normal tissues
irradiation.
IGRT can be performed by imaging modalities using
ionizing radiations such as cone beam computed tomog-
raphy (CBCT) [1] or electronic portal imaging device
(EPID) with fiducials [2, 3], or by imaging techniques
not delivering ionizing radiations such as ultrasounds
(US) [4, 5], electromagnetic transponders [6] and surface
imaging systems [7–9]. Some IGRT modalities detect tar-
get position accounting for the overall localization errors
without distinguishing external patient setup or internal
organ motion (US and electromagnetic transponders),
other IGRT modalities can detect only surrogates of setup
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changes (surface fiducial based imaging systems, bone or
other anatomical landmarks in EPID imaging) and others
can capture both external setup and internal organs varia-
tions (CBCT). The interest to distinguish external setup
and internal target variations resides in the possibility to
identify and correct each error component.
As a matter of fact, CBCT with fiducials is considered
the gold standard to detect both setup and internal
organ variations but it is not usually performed daily in
long course treatments because of the non-negligible
dose of radiation to the patients and staff workload.
Compared to CBCT, surface imaging systems showed
mean positioning errors in the range of 0.1 − 4.0 mm
whereas 3D-US systems showed mean systematic errors
in the range of 1.3–2.5 mm and random errors in the
range of 2.3-2.7 mm [10, 11].
In a previous study, we employed the surface imaging
system AlignRT (VisionRT, London, UK) to analyze inter-
fraction setup variations for prostate cancer [8]. We
observed that measurements by this system were highly
reproducible and correlated with the setup errors detected
by EPID. Similar data were reported by an analogous
study comparing AlignRT with digital portal images [9].
In this work, we compared daily setup variations ob-
served by two IGRT modalities relying on surface im-
aging by AlignRT and trans-abdominal US by Clarity
(Resonant Medical, Elekta, SE) in a cohort of patients
treated for prostate cancer who underwent also regular
quality assurance (QA) procedure by portal imaging.
The aim of the study was to verify the consistency of
the positioning errors registered by the two modalities
and to analyze whether the localization errors mea-
sured by AlignRT could be correlated with those mea-
sured by Clarity.
Methods
Forty patients with organ confined prostate cancer,
staged cT1c–cT3b N0, median iPSA 10.2 ng/ml and
aged 59–81 years (mean 73 years) were enrolled in the
study after adequate informed consent and following our
institutional rules. Patients were candidates to receive
curative radiotherapy to a total dose of 76–78 Gy with
daily conventional fractionation of 2 Gy.
All patients underwent simulation by helical CT-scan
(Lightspeed, General Electric, Milwaukee, WI, USA) in
supine position, using a leg immobilization system
(Combifix-Sinmed, Civco, Kalona, IA, USA), with con-
tiguous slices of 3 mm thickness from L4 to 2 cm below
the ischeal tuberosities. To optimize reproducibility, pa-
tients followed a preparation protocol with empty rec-
tum and full bladder before CT-simulations and before
each treatment session. Three skin tattoos, two laterals
and one anterior, were marked for position verification
by alignment to a laser system. CT data were transferred
to the treatment planning system (TPS) Pinnacle (Philips,
Eindhoven, The Netherlands) by a local network and
target volumes and organs at risk were outlined. Clinical
target volume (CTV) was defined as prostate ± seminal
vesicles according to clinical and imaging data. Planning
target volume (PTV) was obtained by adding 10 mm mar-
gin in all directions, except toward the rectum where the
margin was set to 7 mm.
During the simulation session, we acquired 3-
dimensional (3D) US prostate scan with the Clarity
system installed in the CT-simulation room. The Clarity
system acquires 3D-US pelvic data with a 2D abdominal
US probe outfitted with positional sensors, which is
swept across the patient’s region of interest. An infrared
camera is used to track these sensors so that the position
and orientation of each 2D image may be determined in
order to reconstruct a 3D dataset coregistered with the
CT dataset [12]. In this regard, the radiotherapy plan, in-
cluding contours of CTV, PTV and organs at risk
(OARs), is imported to Clarity workstation and coregis-
tered with US reference image. The contour of the
prostate, based on ultrasound images, is then outlined to
create a reference volume to be used for comparison at
each treatment session. The CT-US image fusion is
performed by a dedicated system implemented in the
Clarity workstation.
Treatment was delivered by a linear accelerator Clinac
DBX (Varian, Milpitas, CA, USA) equipped with a 120
leaves multileaf collimator and an amorphous silicon
electronic portal imaging device (EPID). The treatment
room is equipped with both Clarity and AlignRT sys-
tems. AlignRT is a commercially available 3D-surface
image registration system and the main aspects of its
use and performances were described in previous papers
[8, 13]. The procedure for surface registration, image ac-
quisition, and comparison with the reference image typ-
ically last less than 40 s and the procedure for 3D-US
target verification about 120 s.
At each treatment session after alignment by lasers on
skin tattoos, the surface image of the abdominal and pel-
vic region was acquired by the AlignRT system and core-
gistered with the body reference surface segmented from
the simulation CT-scan. Afterwards, a radiation oncolo-
gist trained in US prostate imaging, acquired pelvic US
image with Clarity system and compared this US image
with the reference one by means of prostate coregistra-
tion. Bladder filling was specifically checked and when-
ever insufficient the patient was invited to drink water.
For both imaging modalities, AlignRT and Clarity, the
shifts on the 3 patient axes anterior-posterior (AP),
cranial-caudal (CC) and later-lateral (LL) were recorded.
Before starting irradiation, portal imaging was per-
formed daily for the first five sessions and then weekly
to cross-validate setup accuracy with bone anatomy
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matching. According to our procedure, the patient was
repositioned and the setup re-verified in case of mis-
alignment >4 mm. At each following treatment session,
the same procedure was performed for all patients and
data were recorded in a data base.
In our series, positioning errors detected by AlignRT
and by Clarity in the frame of reference of the treatment
room have different meanings. By AlignRT, the displace-
ment of the body surface was used as a surrogate of target
position and can be considered as a “fiducial registration
error”. By Clarity, the target was directly monitored by the
IGRT system and the positioning errors are the target
registration errors. The “fiducial registration error” that is
based on patient surface mainly depends on the setup er-
rors and possible patient shape changes, while the target
registration error is affected by setup errors and by organ
motion due to bladder and rectal filling while.
By statistical analysis, the normality Shapiro Wilk
(SW) test was applied to study the distribution of
AlignRT and Clarity measurements. Then, we specifically
investigated whether the positioning errors measured by
AlignRT could correlate to the target error measured by
Clarity. The errors were analyzed by means of descrip-
tive statistics and decomposed in their systematic and
random components. The Wilcoxon test was used to
verify statistical significance of the differences between
the two populations. A p value <0.05 was considered as
statistically significant.
Results
For each IGRT modality, AlignRT and Clarity, 1318 ac-
quisitions were collected and analyzed. The mean, the
standard deviation (SD), the minimum and maximum
values of the positioning errors detected by AlignRT and
Clarity along the main axes are reported in Table 1. Ac-
cording to SW test the collected data were not normally
distributed and the differences between the positioning
errors detected by two imaging systems resulted statisti-
cally significant (p < 0.001) at the Wilcoxon test for each
component along the main axes. The mean, the standard
deviation and the minimum and maximum values of the
daily positioning error differences between the two
modalities are reported in Table 2 and the histograms of
the frequency of these differences are reported in Fig. 1.
In terms of regular QA checks at the setup procedure,
portals showed shifts always inferior to 4 mm along the
three main axes compared to DRRs after alignment by
lasers and surface imaging.
The analysis of the systematic errors for each imaging
modality showed that the mean systematic error de-
tected by AlignRT was 2.2 mm (SD = 3.4 mm) in AP dir-
ection, 3.1 mm (SD = 3.7 mm) in the CC direction and
0.7 mm (SD = 1.9 mm) in the LL direction and the mean
systematic error detected by Clarity was 3.0 mm (SD =
3.1 mm) in AP direction, 2.2 mm (SD = 1.3 mm) in CC
direction and −0.1 mm (SD = 1.0 mm) in LL direction.
The Wilcoxon test showed that differences between
the systematic errors detected by the two modalities
were not statistically significant in AP (p = 0.288) and
CC (p = 0.397) directions, but they were in the LL direc-
tion (p = 0.019). No statistically significant correlation
was found between the systematic errors calculated by
the two modalities as shown in Fig. 2a, b, c.
The mean random error detected by AlignRT was
−0.4 mm (SD = 3.0 mm) in AP direction, 0.1 mm (SD =
2.50 mm) in the CC direction and 0 mm (SD = 1.9 mm)
in the LL direction. The mean random error detected by
Clarity was 0.1 mm (SD = 3.5 mm) in AP direction,
0.3 mm (SD = 3.7 mm) in CC direction and −0.1 mm
(SD = 3.2 mm) in LL direction. The Wilcoxon test
showed that the differences between the random errors
detected by the two modalities were not statistically
significant in AP (p = 0.056), CC (p = 0.177) and LL di-
rections (p = 0.371).
The box plot of the random errors differences between
the two imaging modalities are reported in Fig. 3. The box
plot shows that the 95% confidence interval (CI 95%) of
the random inter-modalities discrepancies is inside the
range from −7 mm to 7 mm, i.e. inside the expansion
margin of PTV applied in AP direction in our series.
Discussion
Intensity-modulation is becoming the standard for
radiotherapy of the intact prostate. With this technique,
tight margins should be applied to the target volume to
limit the dose to normal tissues. It is therefore necessary,Table 1 Descriptive statistic (mean, standard deviation,
maximum and minimum values) of positioning errors (mm)
along the three main axes by the two IGRT modalities, AlignRT
and Clarity
AP CC LL
AlignRT Clarity AlignRT Clarity AlignRT Clarity
Mean 1.8 0.6 3.1 0.6 0.7 -0.0
SD 3.3 5.0 4.4 5.1 2.6 4.9
Max 12.0 20.5 21.2 18.2 10.5 24.3
Min -9.1 -23.8 -18.1 -49.1 -9.4 -17.6
Table 2 Descriptive statistic (mean, standard deviation,
maximum and minimum values) of the daily displacement
differences (mm)
AP CC LL
Mean -1.2 -2.6 -0.7
SD 4.9 6.4 5.0
Max 18.0 15.9 22.1
Min -25.8 -48.8 -22.5
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after the identification and correction of the systematic
error, to accurately localize the target at each radiation
fraction in order to minimize the risk of target missing
related to the random error. For this reason, the use of
imaging modalities without ionizing radiations can en-
courage the use of IGRT on a daily basis [14].
Over the last few years, a number of studies using
video-surface imaging systems for patient setup verifica-
tion have been published [7, 8, 14–19]. Some of them
was performed on breast or intra-thoracic tumors and
showed that surface imaging is a reliable method for pa-
tient position verification and may improve precision
setup. Previous studies from our and other centres
showed that AlignRT can be used also for the setup of
prostate cancer patients [8–10], although the results
showed some differences. Compared to portal images,
Krengli et al. found mean systematic and random errors
in the range of 1.2-2.0 mm and 0.3-0.7 mm, respectively
[8]. Bartoncini et al. observed a concordance of portal
and surface images in lateral direction for an error
threshold of 3 mm and in the longitudinal and vertical
directions for an error threshold of 5 mm [9]. Pallotta et
al. observed mean positioning errors in the range of 0.1
± 2.5 mm and 1.4 ± 4.0 mm between CBCT and sur-
face images, with higher values in longitudinal and
vertical axis and consequent potential improvement in
45% and worsening in 23% of patients by using sur-
face imaging [10].
The potential of verifying the daily target position and
analyzing inter-fraction setup errors by 3D-US imaging
was investigated by other authors [20–25]. Most studies
were performed by combining the use of different IGRT
modalities. The combination of US, CBCT, portal images
and electromagnetic transponders was analyzed by
Mayyas et al. in 27 patients showing comparable (within
3–4 mm) inter-modality shifts [19]. A recent study ana-
lyzed 3 IGRT methods (US, stereoscopic X-ray imaging
of implanted markers and kV CBCT) for prostate
conformal radiation therapy in 186 patients [20]. The
authors found that US guidance requires larger margins
than the other IGRT methods, although they did not
perform a true comparative analysis, since the 3
methods were applied to different patients’ cohorts. A
larger PTV was suggested also by other authors who
found US systems useful but less accurate than x-ray
systems in terms of prostate localization [19–21]. In a
recent study, Li et al. compared US and CBCT in pros-
tate cancer patients with three gold markers. This study
showed that 3D-US is comparable to CBCT. Using seed-
match as reference, mean systematic errors of 3D-US
were 1.3 mm, 0.8 mm and 1.4 mm, and random errors
were 2.5 mm, 2.7 mm and 2.3 mm along lateral, longitu-
dinal and vertical axes, respectively [11].
The present study, aiming at comparing daily varia-
tions obtained by two IGRT modalities is the first report
on the analysis of the combined use of 3D-surface im-
aging and 3D-US in prostate cancer patients.
Our data on setup errors detected by AlignRT and Clar-
ity are quite consistent with those reported by other au-
thors [9, 22]. The asymmetric shape of the histograms and
the non-zero mean value of the daily differences suggest a
systematic component and possibly different sources of er-
rors detected by the two imaging modalities (Fig. 1). The
differences appear to be not only statistically significant but
Fig. 1 Results as histograms for the frequency distribution of the differences between the paired positioning errors detected by AlignRT and
Clarity along the three main axes
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Fig. 2 The graphs (a, b, c) show that the systematic errors detected by AlignRT and Clarity are not correlated. The p values for the linear
regression resulted 0.6013, 0.8936, and 0.6909 respectively for AP, CC, and LL direction
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Fig. 3 Histograms of the paired random errors differences between AlignRT and Clarity in AP (a), CC (b), and LL (c) directions
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also clinically relevant since deviations larger than 10 mm
were detected in relevant subset of the study population.
The differences of systematic errors detected by the two
different IGRT modalities were quite similar in AP and CC
directions but significantly different in LL direction. As a
matter of fact, an additional source of uncertainty in LL
direction could be the precise identification of the lateral
edge of the prostate by US.
The differences between the random errors detected
by the two modalities were not statistically significant
meaning that AlignRT measurements can be predictive
of Clarity displacements after the adjustment for system-
atic errors. Looking at the distribution of the daily ran-
dom error differences between AlignRT and Clarity, we
found that they were generally small, picked around 0
and not exceeding the value of 7 mm in the 95% of the
cases in all the directions, i.e. compatible with our stand-
ard requirements for PTV margins. This finding suggest
that, after the correction for systematic errors, which
can be verified by portals, Align-RT can be reliably used
to monitor inter-fraction reproducibility with errors
compatible with the PTV margins used in our clinical
routine. In this case, we used 3D-US as reference cross
modality but this observation can be extended to the
cases where a CBCT imaging system is available. Usually
CBCT is not performed every day during long treat-
ments with standard fractionations and, in this clinical
scenario, Align-RT could provide accurate surveillance
of interfraction and also intrafraction positioning errors
in a schedule of quality assurance by CBCT.
In our study, the concordance between the two IGRT
modalities after correction for systematic error was
found in condition of constant bladder filling as checked
by 3D-US imaging at each treatment session. Of note,
the differences of random errors detected by the two
modalities in AP direction, which are most likely related
to rectum filling, were quite relevant and almost statisti-
cally significant. These variations were not systematically
checked in our study because undetectable by 3D-US
imaging, but patients were recommended to have a
daily enema to obtain rectum filling as reproducible
as possible. Errors in AP direction detected by Clarity
could be influenced also by a displacement caused by
the probe pressure on the skin, as reported by other
authors [23].
Based on our experience, 3D-surface and 3D-US im-
aging if complementary used, could represent a system
to detect setup errors and organ motions without expos-
ure to ionizing radiations and with a potential reduction
of the cost of IGRT compared to the use of daily cone
beam CT images [25–27].
Crucial aspects of the use of 3D-US imaging are the
education and training of the professionals performing
this technique. In our study, images were acquired by
two radiation oncologists with experience in prostate
management and specific training in US technique.
Our study has some limitations. Trans-abdominal US
is a potentially efficient tool for daily targeting in radio-
therapy; however, it has been associated with significant
inter-user variability, with reports of acceptable images
and acceptable alignments ranging from 68 to 97%
[27–29]. In addition, when compared with prostate posi-
tioning on CT scans or implanted markers, the accuracy
of trans-abdominal US can be questionable as reported by
other authors [5, 19, 30]. Finally, the patient series was not
systematically daily analyzed with CT images by CT-
simulator or CBCT and the results cannot be validated
with such a standard imaging modality, although data
exist in the literature showing a consistency between 3D-
US and CBCT data [22, 23].
Conclusions
Daily variations detected by 3D-surface and 3D-US im-
aging in our series are in the range of the literature data.
The error distributions for both imaging modalities were
asymmetric, suggesting a systematic component with
significant differences between the two imaging modal-
ities. The systematic errors detected by 3D-surface and
3D-US imaging were significantly different only in the
LL direction, possibly related to the difficulty in precise
definition the lateral edge of the prostate by US. The dif-
ferences between the random errors detected by the two
IGRT modalities were not statistically significant, mean-
ing that AlignRT measurements can be predictive of
Clarity displacements after adjustment for systematic er-
rors, given a constant bladder filling as verified in our
study by 3D-US imaging. These findings suggest that the
two techniques could be used as complementary QA
methods in addition to weekly x-rays/cone beam im-
aging and could represent a daily “low-cost” and non-
invasive IGRT modality for prostate cancer patients.
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